The cost-effectiveness of call-back counselling for smoking cessation

Tobacco Control

Volumn 23, Issue 5, 2014, Pages 437-442

  Lal, Anita ^a   Mihalopoulos, Cathy ^a   Wallace, Angela ^b   Vos, Theo ^c  

^a DEAKIN UNIVERSITY   (Australia)

^b UNIVERSITY OF QUEENSLAND   (Australia)

^c UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AUSTRALIA; COST; COST BENEFIT ANALYSIS; COUNSELING; ECONOMICS; FEMALE; HUMAN; MALE; MIDDLE AGED; MOTIVATION; PREVENTION AND CONTROL; PROCEDURES; SMOKING; SMOKING CESSATION; TELEPHONE; TOBACCO DEPENDENCE;

ADULT; COST-BENEFIT ANALYSIS; COSTS AND COST ANALYSIS; COUNSELING; FEMALE; HUMANS; MALE; MIDDLE AGED; MOTIVATION; NORTHERN TERRITORY; SMOKING; SMOKING CESSATION; TELEPHONE; TOBACCO USE DISORDER; WESTERN AUSTRALIA;

EID: 84906215608     PISSN: 09644563     EISSN: 14683318     Source Type: Journal    
DOI: 10.1136/tobaccocontrol-2012-050907     Document Type: Article

References (46)

1. Begg S, Vos T, Barker B, et al. The Burden of Disease and Injury in Australia 2003. PHE 82. Canberra: AIHW, 2007.
2. AUstralian Institute for Health and Welfare. 2010 National Drug Strategy Household Survey report. Drug statistics series no. 25. Cat. no. PHE 145. Canberra: AIHW, 2011.
3. Pauly M, Nicholson S, Xu J, et al. A general model of the impact of absenteeism on employers and employees. Health Econ 2002;11:221-231.
4. Hurley SF. Hospitalisation and costs attributable to tobacco smoking in Australia: 2001-2002. Med J Aust 2006;184:45.
5. Owen N, Davies M. Smokers' preferences for assistance with cessation. Prev Med 1990;19:424-451.
6. Lichtenstein E, Glasgow RE, Lando HA, et al. Telephone counselling for smoking cessation: rationales and meta-analytic review of the evidence. Health Educ Res 1996;11:243-257.
7. Borland R, Segan C, Livingstone P, et al. The effectiveness of call back counselling for smoking cessation: a randomised trial. Addiction 2001;96:881-889.
8. Stead L, Lancaster T, Perera R. Telephone counselling for smoking cessation. cochrane database syst rev 2006;(3):2006.
9. Borland R, Segan CJ. The potential of quitlines to increase smoking cessation. Drug Alcohol Rev 2006;25:73-78.
10. Zhu S, Stretch V, Balabanis M, et al. Telephone counselling for smoking cessation: effects of single session and multiple session interventions. J Cons Clin Psycho 1996;64:202-211.
11. Hollis JF, McAfee TA, Fellows JL, et al. The effectiveness and cost effectiveness of telephone counselling and the nicotine patch in a state tobacco quitline. Tob Control 2007;16(Suppl 1):153-159.
12. McAlister A, Rabius V, Geiger A, et al. Telephone Assistance for Smoking Cessation: One Year Cost Effectiveness Estimations. Tobacco Control 2004;13:85-86.
13. Carter R, Vos T, Moodie M, et al. Priority setting in health: origins, description and application of the Australian Assessing Cost Effectiveness (ACE) initiative. Expert Rev Pharmacoeconomics Outcomes 2008;8:593-617.
14. Carter R, Vos T, Barendregt JJ, et al. ACE-Prevention: Economic Evaluation Protocol. Deakin University & University of Queensland, 2005.
15. Statistics ABo. 6401.0-Consumer Price Index, Australia, Dec 2010, 2011.
16. Australian Institute of Health and Welfare. Health system expenditure on disease and injury in Australia, 2000-01. Second edn. AIHW (Health and Welfare Expenditure Series no. 21). Canberra: Australian Institute of Health and Welfare, 2005.
17. Sassi F. Calculating QALYs, comparing QALY and DALY calculations. Health Policy Plan 2006;21:402-408.
18. Begg S, Vos T, Barker B, et al. The burden of disease and injury in Australia, 2003. Canberra: AIHW, 2007.
19. Australian Bureau of Statistics. Australian Demographic Statistics 3101.0. June quarter [online]. Secondary Australian Demographic Statistics 3101.0. June quarter [online] 2004. http://www.abs.gov.au
20. Australian Institute of Health and Welfare. 2004 National Drug Strategy Household Survey, State and Territory Supplement. Secondary 2004 National Drug Strategy Household Survey, State and Territory Supplement 2005. http://www.aihw.gov.au/ publications/index.cfm/title/10133
21. Bertram M, Lim S, Wallace A, et al. The costs and benefits of smoking cessation aids: making a case for public reimbursement of nicotine replacement therapy in Australia. Tob Control 2007;16:255-260.
22. Stead L, Perera R, Lancaster T. Telephone counselling for smoking cessation. Cochrane Database of Systematic Reviews. Issue 3. The Cochrane Collaboration: John Wiley & Sons, Ltd, 2009.
23. Gartner CE, Barendregt JJ, Hall WD. Predicting the future prevalence of cigarette smoking in Australia: how low can we go and by when? Tob Control 2009;18:183-189.
24. Mikkelsen K, Tonnesen P, Norregaard J. Three-year outcome of two- and three-year sustained abstainers from a smoking cessation study with nicotine patches. J Smoking-Relat Disord 1994;5:95-100.
25. Blondal T, Gudmundsson LJ, Olafsdottir I, et al. Nicotine nasal spray with nicotine patch for smoking cessation: randomised trial with six year follow up. BMJ 1999;318:285-288.
26. Daughton DM, Fortmann SP, Glover E, et al. The smoking cessation efficacy of varying doses of nicotine patch delivery systems 4 to 5 years post-quit day. Prev Med 1999;28:113-118.
27. Yudkin P, Hey K, Roberts S, et al. Abstinence from smoking eight years after participation in randomised controlled trial of nicotine patch. BMJ 2003;327:28-29.
28. ACE Heart Disease. Economic Evaluation Protocol for the ACE-Heart Disease Study. University of Melbourne, University of Queensland, 2003.
29. Gold M, Siegal J, Russell L, Weinstein M.eds. Cost-Effectiveness in Health and Medicine. New York: Oxford University Press, 1996.
30. Peto R, Lopez AD, Boreham J, et al. Mortality from tobacco in developed countries: indirect estimation from national vital statistics. Lancet 1992;339:1268-1278.
31. Dunstan DW, Zimmet PZ, Welborn TA, et al. The Australian diabetes, obesity and lifestyle study (AusDiab)-methods and response rates. Diabetes Res Clin Pract 2002;57:119-129.
32. Ezzati M, Lopez AD. Measuring the accumulated hazards of smoking: global and regional estimates for 2000. Tob Control 2003;12:79-85.
33. Mathers C, Vos T, Stevenson C. The burden of disease and injury in Australia. Canberra: Australian Institute of Health and Welfare, 1999.
34. Department of Health and Ageing. Medicare benefits schedule. Canberra, 2003.
35. Australian Bureau of Statistics. Employee earnings and hours 6305.0, 2002.
36. Australian Institute of Health and Welfare. Health and welfare expenditure series, disease costs and impacts studies. Canberra: Australian Institute of Health and Welfare, 2001.
37. ACE Prevention. ACE prevention economic protocol: the school of population health. The University of Queensland and the University of Melbourne, 2006.
38. Jacobs P, Fassbender K. The measurement of indirect costs in the health economics evaluation literature. A review. Int J Technol Assess Health Care 1998;14:799-808.
39. Australian Bureau of Statistics. 6301.0 Average weekly earnings. Canberra, 2000.
40. Australian Bureau of Statistics. 6220.0-Persons not in the labour force, Australia. Canberra, 2001.
41. Department of Health and Ageing. Schedule of pharmaceutical benefits. Canberra: Commonwealth of Australia, 2010.
42. George B, Harris A, Mitchell A. Cost-effectiveness analysis and the consistency of decision making: evidence from pharmaceutical reimbursement in australia (1991 to 1996). Pharmacoeconomics 2001;19:1103-1109.
43. Arnesen T, Nord E. The value of DALY life: problems with ethics and validity of disability adjusted life years. BMJ 1999;319:1423-1425.
44. Anand S, Hanson K. Disability-adjusted life years: a critical review. J Health Econ 1997;16:685-702.
45. Tengs TO, Osgood ND, Chen LL. The cost-effectiveness of intensive national school-based anti-tobacco education: results from the tobacco policy model. Prev Med 2001;33:558-570.
46. Hurley S, Matthews J. The quit benefits model: a Markov model for assessing the health benefits and health care cost savings of quitting smoking. Cost Effectiveness Resource Allocation 2007;5:2.